MIC
NVO

Meridian Investment Counsel’s Novo Nordisk NVO Stock Holding History

Meridian Investment Counsel’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02M Buy
63,091
+899
+1% +$38.6K 0.65% 47
2026
Q1 		$2.29M Sell
62,192
-60
-0.1% -$2.84K 0.54% 60
2025
Q4 		$3.17M Buy
62,252
+6,760
+12% +$346K 0.76% 35
2025
Q3 		$3.08M Buy
55,492
+3,105
+6% +$182K 0.76% 33
2025
Q2 		$3.62M Buy
52,387
+6,140
+13% +$418K 0.98% 28
2025
Q1 		$3.21M Buy
46,247
+550
+1% +$45.4K 0.95% 29
2024
Q4 		$3.93M Buy
45,697
+22,314
+95% +$2.41M 1.17% 21
2024
Q3 		$2.78M Sell
23,383
-635
-3% -$84.7K 0.84% 31
2024
Q2 		$3.43M Sell
24,018
-400
-2% -$53K 1.08% 21
2024
Q1 		$3.14M Sell
24,418
-512
-2% -$60.9K 1.04% 25
2023
Q4 		$2.58M Buy
24,930
+100
+0.4% +$9.89K 0.89% 31
2023
Q3 		$2.26M Sell
24,830
-1,030
-4% -$90.7K 0.85% 34
2023
Q2 		$2.09M Sell
25,860
-220
-0.8% -$18K 0.75% 39
2023
Q1 		$2.08M Hold
26,080
– – 0.79% 38
2022
Q4 		$1.76M Sell
26,080
-50
-0.2% -$2.93K 0.7% 43
2022
Q3 		$1.3M Buy
26,130
+290
+1% +$15.5K 0.58% 52
2022
Q2 		$1.44M Hold
25,840
– – 0.59% 52
2022
Q1 		$1.44M Buy
25,840
+200
+0.8% +$10.3K 0.5% 61
2021
Q4 		$1.44M Sell
25,640
-1,300
-5% -$70.4K 0.48% 61
2021
Q3 		$1.29M Hold
26,940
– – 0.47% 67
2021
Q2 		$1.13M Hold
26,940
– – 0.4% 73
2021
Q1 		$908K Hold
26,940
– – 0.35% 80
2020
Q4 		$941K Buy
26,940
+4,380
+19% +$151K 0.4% 70
2020
Q3 		$783K Hold
22,560
– – 0.38% 67
2020
Q2 		$739K Sell
22,560
-20
-0.1% -$638 0.38% 68
2020
Q1 		$680K Sell
22,580
-400
-2% -$11.9K 0.44% 65
2019
Q4 		$665K Hold
22,980
– – 0.33% 79
2019
Q3 		$594K Sell
22,980
-150
-0.6% -$3.79K 0.32% 86
2019
Q2 		$590K Sell
23,130
-600
-3% -$14.8K 0.33% 81
2019
Q1 		$621K Sell
23,730
-800
-3% -$19.7K 0.36% 78
2018
Q4 		$565K Sell
24,530
-1,950
-7% -$43.3K 0.37% 77
2018
Q3 		$624K Hold
26,480
– – 0.34% 84
2018
Q2 		$611K Sell
26,480
-400
-1% -$9.51K 0.35% 81
2018
Q1 		$662K Buy
26,880
+200
+0.7% +$5.25K 0.38% 77
2017
Q4 		$716K Hold
26,680
– – 0.39% 74
2017
Q3 		$642K Hold
26,680
– – 0.37% 77
2017
Q2 		$572K Hold
26,680
– – 0.34% 82
2017
Q1 		$457K Sell
26,680
-300
-1% -$5.22K 0.28% 97
2016
Q4 		$484K Hold
26,980
– – 0.32% 89
2016
Q3 		$561K Buy
26,980
+950
+4% +$23.6K 0.38% 77
2016
Q2 		$700K Sell
26,030
-1,550
-6% -$42.5K 0.48% 67
2016
Q1 		$747K Hold
27,580
– – 0.52% 63
2015
Q4 		$801K Hold
27,580
– – 0.59% 55
2015
Q3 		$748K Sell
27,580
-2,700
-9% -$76.4K 0.61% 57
2015
Q2 		$829K Sell
30,280
-2,100
-6% -$59K 0.59% 58
2015
Q1 		$864K Buy
32,380
+1,200
+4% +$27.6K 0.6% 57
2014
Q4 		$660K Buy
31,180
+1,450
+5% +$32.4K 0.48% 67
2014
Q3 		$708K Sell
29,730
-800
-3% -$18.4K 0.53% 63
2014
Q2 		$705K Sell
30,530
-1,850
-6% -$40.8K 0.54% 65
2014
Q1 		$739K Sell
32,380
-5,450
-14% -$116K 0.63% 55
2013
Q4 		$699K Buy
+37,830
New +$659K 0.59% 58

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
GIM
Generate Investment Management Auckland, New Zealand $2.43B AUM 37.24% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return

Meridian Investment Counsel's NVO Position: Q2 2026 in Review

Meridian Investment Counsel increased its Novo Nordisk (NVO) stake by 1.4% in Q2 2026, buying an estimated $38.6K and bringing the position to 63,091 shares worth $3.02M. The position accounts for 0.65% of the portfolio, ranked #47.

Meridian Investment Counsel first reported a position in NVO in Q4 2013 and has held it in 51 quarters since. The position peaked at $3.93M in Q4 2024. 516 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Meridian Investment Counsel held 63,091 shares of Novo Nordisk worth $3.02M as of Q2 2026.
  • Meridian Investment Counsel bought 899 Novo Nordisk shares in Q2 2026, an estimated $38.6K.
  • Novo Nordisk made up 0.65% of Meridian Investment Counsel's portfolio in Q2 2026, its #47 holding.
  • Meridian Investment Counsel first reported a position in Novo Nordisk in Q4 2013 and has held it in 51 quarters since.
  • Meridian Investment Counsel's Novo Nordisk position peaked at $3.93M in Q4 2024.
  • 516 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Meridian Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.